ANCA-associated vasculitis: an update
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …
Wegener granulomatosis: an analysis of 158 patients
GS Hoffman, GS Kerr, RY Leavitt… - Annals of internal …, 1992 - acpjournals.org
▪ Objective: To prospectively study the clinical features, pathophysiology, treatment, and
prognosis of Wegener granulomatosis.▪ Design: Of the 180 patients with Wegener …
prognosis of Wegener granulomatosis.▪ Design: Of the 180 patients with Wegener …
[KNJIGA][B] Oral and Maxillofacial Pathology-E-Book: Oral and Maxillofacial Pathology-E-Book
BW Neville, DD Damm, CM Allen, AC Chi - 2015 - books.google.com
Be prepared to diagnose and manage any condition you encounter in your practice! This
bestselling reference gives you direct access to a complete range of full-color clinical …
bestselling reference gives you direct access to a complete range of full-color clinical …
Long-term patient survival in ANCA-associated vasculitis
O Flossmann, A Berden, K de Groot, C Hagen… - Annals of the …, 2011 - ard.bmj.com
Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and …
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and …
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
RY Leavitt, AS Fauci, DA Bloch, BA Michel… - Arthritis & …, 1990 - Wiley Online Library
Criteria for the classification of Wegener's granulomatosis (WG) were developed by
comparing 85 patients who had this disease with 722 control patients with other forms of …
comparing 85 patients who had this disease with 722 control patients with other forms of …
Classification, epidemiology and clinical subgrou** of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
It is now 25 years since the first European studies on vasculitis—the anti-neutrophil
cytoplasmic antibody (ANCA) standardization project. Over that period of time, there have …
cytoplasmic antibody (ANCA) standardization project. Over that period of time, there have …
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial
K De Groot, L Harper, DRW Jayne… - Annals of internal …, 2009 - acpjournals.org
Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
E Ntatsaki, D Carruthers, K Chakravarty… - …, 2014 - academic.oup.com
Eleana Ntatsaki1, 2, David Carruthers3, Kuntal Chakravarty4, David D'Cruz5, Lorraine
Harper6, David Jayne7, Raashid Luqmani8, John Mills9, Janice Mooney10, Michael …
Harper6, David Jayne7, Raashid Luqmani8, John Mills9, Janice Mooney10, Michael …
Small-vessel vasculitis
JC Jennette, RJ Falk - New England Journal of Medicine, 1997 - Mass Medical Soc
Vasculitis is inflammation of vessel walls. It has many causes, although they result in only a
few histologic patterns of vascular inflammation. Vessels of any type in any organ can be …
few histologic patterns of vascular inflammation. Vessels of any type in any organ can be …
Birmingham vasculitis activity score (BVAS) Dim system necrotizinig vasculitis
RA Luqmani, PA Bacon, RJ Moots… - … Journal of Medicine, 1994 - academic.oup.com
The continuing morbidity of patients with vasculitis despite the improved prognosis with
aggressive therapy, underlines the need for accurate disease assessment We have devised …
aggressive therapy, underlines the need for accurate disease assessment We have devised …